Eastover Investment Advisors LLC Abb Vie Inc. Transaction History
Eastover Investment Advisors LLC
- $221 Million
- Q3 2025
A detailed history of Eastover Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eastover Investment Advisors LLC holds 35,284 shares of ABBV stock, worth $8.26 Million. This represents 3.7% of its overall portfolio holdings.
Number of Shares
35,284
Previous 37,449
5.78%
Holding current value
$8.26 Million
Previous $6.95 Million
17.52%
% of portfolio
3.7%
Previous 3.12%
Shares
23 transactions
Others Institutions Holding ABBV
# of Institutions
4,488Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...